Cellular / Tissue-Based Products (CTPs)
“Research Not Rebates”… and “Our IRB Status with the Department of Health and Human Services…” Hmmmmmm……..
I worry that this is a thinly disguised rebate program, and it would be a shame if that approach backfires on legitimate research initiatives.
Can Someone Explain the Math on the Patient Copay for CTPs (Skin Substitutes)?
Where I come from, we’d say that something about this seems as crooked as a dog’s hind leg. However, it’s possible that I just don’t understand it, so I hope you will explain it to me.
How We Got Here – Answers to the Questions I Have Been Asking
With these answers, perhaps we can begin talk about what kind of policies would FIX this mess, pretending we could get anyone to listen.
The Other Side of the CTP/Skin Substitute Story – How Poorly-Crafted CMS Policies for Package Pricing in HOPDs Created This Mess
HOPDs lose money on CTP/Skin Substitute applications, while doctor’s offices make huge profits from the product. Why is this OK?
“We Will All Lose in the End.” Let’s Discuss the Moral Hazard of the CTP (Skin Substitute) Industry
If you want to send me a message to post anonymously, email me and I will review it and perhaps discuss it with you further.
If You Wonder Why CMS is Looking at Skin Subs, Check Out These Claims…
Can anyone tell me why no invoice is needed to submit these claims and exactly how these profits are being realized?
CTP/Skin Sub Ads to Doctors – Am I the ONLY Person Who Thinks There’s Something Wrong?
Feel free to send me the ads that you have seen. I will redact the name of the company and post them.
The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.